TCG
MDT icon

Transcendent Capital Group’s Medtronic MDT Stock Holding History

Transcendent Capital Group’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-115
Closed -$9.19K – 286
2024
Q4 		$9.19K Hold
115
– – ﹤0.01% 348
2024
Q3 		$10.4K Hold
115
– – 0.01% 357
2024
Q2 		$9.05K Hold
115
– – 0.01% 330
2024
Q1 		$10K Hold
115
– – 0.01% 328
2023
Q4 		$9.47K Buy
+115
New +$8.77K 0.01% 271

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Transcendent Capital Group's MDT Position: Q1 2025 in Review

Transcendent Capital Group sold out of Medtronic (MDT) in Q1 2025, closing a stake of 115 shares — an estimated $9.19K sold.

Transcendent Capital Group first reported a position in MDT in Q4 2023 and held it in 5 quarters. The position peaked at $10.4K in Q3 2024. 2,170 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Transcendent Capital Group reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
  • Transcendent Capital Group sold 115 Medtronic shares in Q1 2025, an estimated $9.19K.
  • Transcendent Capital Group first reported a position in Medtronic in Q4 2023 and held it in 5 quarters.
  • Transcendent Capital Group's Medtronic position peaked at $10.4K in Q3 2024.
  • 2,170 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Transcendent Capital Group's 13F filing for Q1 2025, filed 2 May 2025.